A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study

Thompson, 1996, Remifentnail—an opioid for the 21st century, Br J Anaesth, 76, 341, 10.1093/bja/76.3.341

Egan, 1993, The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers, Anesthesiology, 79, 881, 10.1097/00000542-199311000-00004

Kapila, 1995, Measured context-sensitive half-times of remifentanil and alfentanil, Anesthesiology, 83, 968, 10.1097/00000542-199511000-00009

Bekker, 2000, The recovery of cognitive function after remifentanil-nitrous oxide anesthesia is faster than after an isoflurane-nitrous-oxide-fentanyl combination in elderly patients, Anesth Analg, 91, 117, 10.1213/00000539-200007000-00022

Larsen, 2000, Recovery of cognitive function after remifentanil-propofol anesthesia, Anesth Analg, 90, 168, 10.1097/00000539-200001000-00035

Schuttler, 1997, A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery, Anaesthesia, 52, 307, 10.1111/j.1365-2044.1997.24-az0051.x

Hogue, 1996, A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery, Anesth Analg, 83, 279, 10.1213/00000539-199608000-00014

Grasela, 1993, The role of pharmacoepidemiology research in postmarketing surveillance and anesthesia practice/critical care medicine, Anesth Analg, 77, S44

Twersky, 2001, Hemodynamic and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients, J Clin Anesth, 13, 407, 10.1016/S0952-8180(01)00292-6

Fleisher, 2001, Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia?, J Clin Anesth, 13, 401, 10.1016/S0952-8180(01)00291-4

Joshi, 2000, Is there a learning curve associated with the use of remifentanil?, Anesth Analg, 91, 1049

Grasela, 1996, Pharmacoepidemiology, Ann Pharmacother, 30, 188, 10.1177/106002809603000216

Talbot, 1998, Pharmacovigilance in the pharmaceutical industry, Br J Clin Pharmacol, 45, 427, 10.1046/j.1365-2125.1998.00713.x

McLeskey, 1993, Adverse events in a multicenter phase IV study of propofol, Anesth Analg, 77, S3